- 基本信息
导师姓名:
|
葛盛芳
|
学科代码:
|
100212
|
|
性别:
|
男
|
学科名称:
|
眼科学
|
培养单位:
|
附属第九人民医院
|
三级学科
|
|
导师类型:
|
博士生导师
|
专业领域名称:
|
|
联系方式:
|
geshengfang@hotmail.com
021-53314247
|
专业领域代码:
|
|
邮编:
|
200011
|
邮箱地址:
|
geshengfang@hotmail.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
中国生物物理学会 辐射与环境专业委员会常务委员
|
上海市眼眶病眼肿瘤重点实验室副主任
|
上海法院知识产权技术咨询专家
|
曾兼任上海市生物化学与分子生物学学会理事。任<转化医学杂志>编委,《上海交通大学学报(医学版)》审稿人。
|
教育部学位与研究生教育发展中心评审专家
|
- 科研项目
12275178 | 药物清除放射诱导的衰老细胞提高葡萄膜黑色素瘤辐射效应的机制研究 | 国家自然科学基金项目 |
2023-01~2026-12
|
56万元
| 课题负责人 |
U1932135 | 富氧碳基纳米材料协同重离子放疗杀伤肿瘤的作用及机理研究 | 国家自然科学基金项目 |
2020-01~2023-12
|
60万元
| 课题负责人 |
81772875 | LncRNA L12–PTPRZ1通路在葡萄膜黑色素瘤靶向治疗中的作用机理研究 | 国家自然科学基金项目 |
2018-01~2021-12
|
55万元
| 课题负责人 |
U1432117 | lncRNA-29314916-CCNB2通路在重离子放疗中的辐射增敏机理研究 | 国家自然科学基金项目 |
2015-01~2017-12
|
68万元
| 课题负责人 |
201402014 | 常见眼恶性肿瘤诊疗新技术、规范及其应用研究 | 国家卫计委公益性行业科研专项项目 |
2014-06~2017-06
|
1262万元
| 课题参与人 |
13JC1406202 | lncRNA-15:23930854通过调控有关蛋白参与低氧诱导的癌细胞恶性转化过程 | 上海市基础研究重点 |
2013-09~2016-08
|
30万元
| 课题负责人 |
XDA01040411 | 肿瘤干细胞分离、鉴定及特异标记物的研究及基于肿瘤干细胞特征的靶向药物研究 | 中国科学院战略性先导科技专项资助A类 |
2013-01~2017-12
|
200万元
| 课题参与人 |
81172323 | 导入PRC2基因修复肿瘤细胞IGF2遗传印迹丢失的作用及其机制研究 | 国家自然科学基金项目 |
2012-01~2015-12
|
64万元
| 课题负责人 |
10979034 | 重离子协同腺病毒载体靶向杀灭肿瘤细胞的机理研究 | 国家自然科学基金项目 |
2010-01~2012-12
|
54万元
| 课题负责人 |
2010CB529902 | 靶向基因治疗的应用基础研究 | 973计划 |
2010-01~2014-12
|
144万元
| 课题参与人 |
091024851 | 基因-MicroRNA共表达新型腺病毒对荷瘤鼠肿瘤生长的影响 | 第三期国家大学生创新性实验计划项目 |
2009-11~2011-06
|
3万元
| 课题负责人 |
09ZZ110 | 基因-小干扰RNA共表达肿瘤基因治疗新策略的研究 | 上海市教委 |
2009-01~2011-12
|
15万元
| 课题负责人 |
08ZR1412500 | 基因-小干扰RNA共表达策略在肿瘤基因治疗中的应用研究 | 上海市科委 |
2008-11~2010-12
|
10万元
| 课题负责人 |
ZD0702 | Trail-siPROM1共表达双靶点胃肠肿瘤干细胞基因治疗新策略研究 | 仁济医院合作研究项目 |
2007-10~2010-09
|
25万元
| 课题负责人 |
- 学术论文
Fu Y, Yu J, Li F,
|
Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification.
|
J Exp Clin Cancer Res(IF 12.658 )
|
2022
|
41(1):144
|
Yao Y, Gu X, Xu X,, Jia R
|
Novel insights into RB1 mutation
|
Cancer letters (IF 9.756)
|
2022
|
547:215870
|
Chai P, Jia R, Li Y, Zhou C, Gu X, Yang L, Shi H, Tian H, Lin H, Yu J, Zhuang A,, Jia R, Fan X.
|
Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.
|
Prog Retin Eye Res(IF19.704)
|
2022
|
89:101030
|
Jia S, Zhu T, Shi H, Zong C, Bao Y, Wen X,, Ruan J, Xu S, Jia R, Fan X.
|
American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
|
Ophthalmology(IF14.277)
|
2022
|
129(7):771-780.
|
Tian H, Shi H, Yu J,, Ruan J
|
Biophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT
|
Global challenges (IF 5.135)
|
2022
|
6(6):2100094
|
Huang Y, Zhang L, Ji Y, Deng H, Long M,, Su Y, Chan SY, Loh XJ, Zhuang A, Ruan J
|
A non-invasive smart scaffold for bone repair and monitoring.
|
Bioactive materials (IF 16.874)
|
2022
|
19:499-510
|
Yu J, Chai P, Xie M,, Ruan J, Fan X, Jia R
|
Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.
|
Genome biology (IF 17.906)
|
2021
|
22(1):85
|
Lin H, Yu J, Gu X,, Fan X
|
Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology.
|
Clinical and translational medicine (IF 8.554)
|
2021
|
11(12):e636
|
Yang L, Gu X, Yu J,, Fan X.
|
Oncolytic Virotherapy: From Bench to Bedside
|
Frontiers in cell and developmental biology (IF 6.081)
|
2021
|
9:790150
|
Wang S, Chen B, Ouyang L, Wang D, Tan J, Qiao Y,, Ruan J, Zhuang A, Liu X, Jia R
|
A Novel Stimuli-Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene-Targeted Therapy towards Uveal Melanoma.
|
Advanced science (IF 17.521)
|
2021
|
8(18):e2004721
|
Chai P, Yu J, Wang X,, Jia R
|
BMP9 promotes cutaneous wound healing by activating Smad1/5 signaling pathways and cytoskeleton remodeling.
|
Clinical and translational medicine (IF 8.554)
|
2021
|
11(1):e271
|
Gu X, Xie M, Jia R,
|
Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis.
|
Frontiers in medicine (IF 5.058)
|
2021
|
8:675703
|
Ding Y, Yu J, Chen X, Wang S, Tu Z, Shen G, Wang H, Jia R,, Ruan J, Leong KW, Fan X
|
Dose-Dependent Carbon-Dot-Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism.
|
Advanced science (IF17.521)
|
2021
|
8(8):2002404
|
Li P, He J, Yang Z,, Zhang H, Zhong Q, Fan X
|
ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression.
|
Autophagy (IF 13.391)
|
2020
|
16(7), 1186–1199
|
Fan J, Xu Y, Wen X,, Jia R, Zhang H, Fan X
|
A Cohesin-Mediated Intrachromosomal Loop Drives Oncogenic ROR lncRNA to Accelerate Tumorigenesis.
|
Molecular therapy : the journal of the American Society of Gene Therapy (IF 12.910)
|
2020
|
27(12), 2182–2194
|
Wen X, Wang H, Chai P, Fan J, Zhang X, Ding T, Jia R,, Zhang H, Fan X
|
An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma.
|
Molecular therapy oncolytics (IF 6.311)
|
2020
|
18:317-325
|
Liu T, Zhang H, Fang J, Yang Z, Chen R, Wang Y, Zhao X,, Yu J, Huang J
|
AGO2 phosphorylation by c-Src kinase promotes tumorigenesis.
|
Neoplasia (IF 6.218)
|
2020
|
22(3):129-141
|
Yu J, Loh XJ, Luo Y,, Fan X, Ruan J
|
Insights into the epigenetic effects of nanomaterials on cells.
|
Biomaterials science (IF 7.590)
|
2020
|
8(3), 763–775
|
Chai P, Yu J,, Jia R, Fan X
|
Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
|
Journal of hematology & oncology (IF 23.168)
|
2020
|
13(1):43
|
Wang H, Yang J, Pan H, Tai MC, Maher MH, Jia R,, Lu L
|
Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway.
|
OncoTargets and therapy (IF 4.345)
|
2020
|
13:3903-3920
|
Li F, Xu Y, Xu X,, Zhang F, Zhang H, Fan X
|
lncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop.
|
Molecular therapy. Nucleic acids (IF 10.183)
|
2020
|
22:456-470
|
Gu X, Yu J, Chai P,, Fan X
|
Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression.
|
Journal of experimental & clinical cancer research : CR (IF 12.658)
|
2020
|
39(1):215
|
Ding X, Cao Y, Xing Y,, Lin M, Li J
|
TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease.
|
Ocular immunology and inflammation (IF 3.728)
|
2020
|
28(2), 288–297
|
Chai P, Yu J,, Jia R*, Fan X*.
|
Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
|
J Hematol Oncol (IF 23.168)
|
2020
|
13(1):43
|
Xie M, Yu J,, Huang J, Fan X
|
SUMOylation homeostasis in tumorigenesis.
|
Cancer letters (IF 9.756)
|
2020
|
469:301-309
|
Ji Y, Zhou Y, Shen Q, Xu W,, Gu L, Fan X
|
Prediction of late displacement of the globe in orbital blowout fractures.
|
Acta ophthalmologica (IF 3.988)
|
2020
|
98(2), e197–e202
|
He X, Chai P, Li F, Zhang L, Zhou C, Yuan X, Li Y, Yang J, Luo Y,, Zhang H, Jia R, Fan X
|
A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.
|
Molecular cancer (IF 41.444)
|
2020
|
19(1):115
|
Chai P, Yu J, Jia R, Wen X, Ding T, Zhang X, Ni H, Jia R,, Zhang H, Fan X
|
Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.
|
Nucleic acids research (IF 19.160)
|
2020
|
48(21):12135-12150
|
Li Y, He J, Qiu C, Shang Q, Qian G, Fan X*,, Jia R*.
|
The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.
|
J Cell Biochem. (IF 4.480)
|
2019
|
120(4):5766-5776.
|
Chen J, Li F, Xu Y, Zhang W, Hu Y, Fu Y, Xu W,, Fan X, Lu L
|
Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition.
|
Experimental eye research (IF 3.770)
|
2019
|
184:64-71
|
Ding Y, Yang J, Ma Y, Yao T, Chen X,, Wang L, Fan X
|
MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.
|
Journal of experimental & clinical cancer research : CR (IF 12.658)
|
2019
|
38(1), 498
|
Jia R, Chai P, Wang S, Sun B, Xu Y, Yang Y,, Jia R, Yang YG, Fan X
|
m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation.
|
Molecular cancer (IF 41.444)
|
2019
|
18(1), 161
|
Shang Q, Li Y, Wang H,, Jia R.
|
Altered expression profile of circular RNAs in conjunctival melanoma.
|
Epigenomics. (4.357)
|
2019
|
11(7):787-804.
|
Zhao H, Pan H, Wang H, Chai P,, Jia R, Fan X.
|
SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27.
|
Onco Targets Ther. (IF 4.345)
|
2019
|
12:4297-4308
|
Shang Q, Yang Z, Jia R,
|
The novel roles of circRNAs in human cancer.
|
Mol Cancer (IF 41.444)
|
2019
|
18(1):6
|
Yang Z, Gu Q, Wang Y, Liu B, Zhou G, Shao C, Ruan J, Jia R,
|
Heavy-Ion Carbon Radiation Regulates Long Non-Coding RNAs in Cervical Cancer HeLa Cells.
|
Journal of Cancer (IF 4.478)
|
2019
|
10(21), 5022–5030
|
Chai P, Jia R, Jia R, Pan H, Wang S, Ni H, Wang H, Zhou C, Shi Y,, Zhang H, Fan X.
|
Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.
|
Nucleic Acids Res(IF 19.160)
|
2018
|
46(12):6041-6056
|
Li Y, Shang Q, Li P, Cao J, Zhu L, Jager MJ, Fan X,, Jia R
|
Characterization of a conjunctival melanoma cell line CM-AS16, newly-established from a metastatic Han Chinese patient.
|
Exp Eye Res (IF 3.770)
|
2018
|
173:51-63
|
Ruan J, Wang Y, Li F, Jia R, Zhou G, Shao C, Zhu L, Cui M, Yang DP,
|
Graphene Quantum Dots for Radiotherapy.
|
ACS Appl Mater Interfaces.(IF10.383)
|
2018
|
10(17):14342-14355
|
Li P, Li Y, Zhu L, Yang Z, He J, Wang L, Shang Q, Pan H, Wang H, Ma X, Li B, Fan X,, Jia R*, Zhang H*.
|
Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis.
|
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (IF 6.633)
|
2017
|
864(3):709-720
|
Li G, Wang L, Jiang Y, Kong X, Fan Q,, Hao Y.
|
Upregulation of Akt signaling enhances femoral fracture healing by accelerating atrophic quadriceps recovery.
|
Biochim Biophys Acta
|
2017
|
1863(11):2848-2861
|
Li Y, Jia R,
|
Role of Epigenetics in Uveal Melanoma.
|
Int J Mol Med (IF 5.314)
|
2017
|
40(4):979-986
|
Bi J, Li P, Li C, He J, Wang Y, Zhang H, Fan X, Jia R,
|
The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration
|
Tumour Biol
|
2016
|
37(3):4175-82
|
Zhang L, Jia R, Zhao J, Fan J, Zhou Y, Han B, Song X, Wu L, Zhang H, Song H,, Fan X*
|
Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma
|
Tumour Biol.
|
2015
|
36(4):2409-20
|
Pan H, Jia R, Zhang L, Xu S, Wu Q, Song X, Zhang H,, Xu XL*, Fan X*
|
BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
|
Int J Biochem Cell Biol (5.652)
|
2015
|
60(3):176-84
|
Fan J, Xing Y, Wen X, Jia R, Ni H, He J, Ding X, Pan H, Qian G,, Hoffman AR, Zhang H, Fan X
|
Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis
|
Genome Biol (IF 17.906)
|
2015
|
16(1):139-156
|
Bi J,
|
Potential roles of BMP9 in liver fibrosis
|
Int J Mol Sci (IF 6.208)
|
2014
|
15(11):20656-67
|
Zhang H, Zeitz MJ, Wang H, Niu B,, Li W, Cui J, Wang G, Qian G, Higgins MJ, Fan X, Hoffman AR, Hu JF.
|
Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus
|
J Cell Biol (IF8.077)
|
2014
|
204(1):61-75
|
Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, He F, Lin M,, Fan X*.
|
Pingyangmycin as First-Line Treatment for Low-Flow Orbital or Periorbital Venous Malformations: Evaluation of 33 Consecutive Patients
|
JAMA Ophthalmol (IF 8.253)
|
2014
|
132(8):942-8
|
Wang J, Jia R, Zhang Y, Xu X, Song X, Zhou Y, Zhang H,, Fan X*.
|
The role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells
|
Tumour Biol
|
2014
|
35(2):1169-75
|
Ye L, Zhao X, Lu J, Qian G, Zheng JC,
|
Knockdown of TIGAR by RNA interference induces apoptosis and autophagy in HepG2 hepatocellular carcinoma cells.
|
Biochem Biophys Res Commun (IF 3.322)
|
2013
|
436(9):1-6
|
Zhang H, Jiao W, Sun L, Fan J, Chen M, Wang H, Xu X, Shen A, Li T, Niu B,, Li W, Cui J, Wang G, Sun J, Fan X, Hu X, Mrsny RJ, Hoffman AR, Hu JF
|
Intrachromosomal Looping Is Required for Activation of Endogenous Pluripotency Genes during Reprogramming
|
Cell Stem Cell (IF25.269)
|
2013
|
13(1):30-5
|
Cun B, Song X, Jia R, Wang H, Zhao X, Liu B,, Fan X
|
Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA
|
Tumour Biol
|
2013
|
34(3):1801-6
|
Zhang Y, Jia R, Wang J, Xu X, Yao Y,, Fan X*
|
Targeted Silencing of MART-1 Gene Expression by RNA Interference Enhances the Migration Ability of Uveal Melanoma Cells
|
Int. J. Mol. Sci (IF 6.208)
|
2013
|
14(4):15092-15104
|
Li C, Chen P, Zhang J, Zhang L, Huang X, Yao Y, Che X, Fan X,, Wang Z.
|
Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway.
|
Invest Ophthalmol Vis Sci (IF 4.925)
|
2013
|
54(12):1-12
|
Li C, Wu Q, Liu B, Yao Y, Chen Y, Zhang H, Wang C, Cao J,
|
Detection and Validation of Circulating Endothelial Cells, a Blood-based Diagnostic Marker of Acute Myocardial Infarction
|
PLoS ONE (IF 3.752)
|
2013
|
8(3):58478-0
|
Zhang J, Sun Q, Zhang Z,, Han ZG, Chen WT
|
Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop
|
Oncogene (IF 8.756)
|
2012
|
32(1):61-69
|
Hao Y, Ma Y, Wang X, Jin F,
|
Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur.
|
J Orthop Res (IF 3.102)
|
2012
|
30(4):574-80
|
Xin Song, Haibo Wang, Renbing Jia, Biyun Cun, Xiaoping Zhao, Yixiong Zhou, Xiaofang Xu, Guanxiang Qian,
|
Combined treatment with an oncolytic adenovirus and vincristine antitumor activity against retinoblastoma cells
|
Int. J. Mol. Sci. (IF 6.208)
|
2012
|
13(0):10736-10749
|
Wang H, Song X, Zhang H, Zhang J, Shen X, Zhou Y, Fan X, Dai L, Qian G, Hoffman AR, Hu JF,
|
Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts
|
Int J Cancer(IF 7.316)
|
2012
|
15;130 (2):443-53
|
Sun J, Zhou J, Zhao P, Lian J, Zhu H, Zhou Y, Sun Y, Wang Y, Zhao L, Wei Y, Wang L, Cun B, Ge S,
|
High Prevalence of Myopia and High Myopia in 5060 Chinese University Students in Shanghai
|
Invest Ophthalmol Vis Sci. (IF 4.925)
|
2012
|
53(12):7504-9
|
Huang X, Jia R, Zhao X, Liu B, Wang H, Wang J, Zhou Y, Cun B,, Fan X.
|
Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines
|
Br J Ophthalmol (IF 5.908)
|
2012
|
96(10):1331-8
|
Wang Z, Jia R,, He T, Zhang Y, Yang Y, Wang Y, Shi W, Ji Y, Ye F, Chen P, Lu J, Sun J, Xu X, Zhou Y, Gu P, Luo M, Lu H, Fan X
|
Ocular Complications of Human Immunodeficiency Virus Infection in Eastern China
|
Am J Ophthalmol (IF 5.488)
|
2012
|
153(2):363-369
|
Cun B, Song X, Jia R, Zhao X, Wang H,, Fan X
|
Combination of oncolytic adenovirus and dacarbazine enhances antitumor ability against uveal melanoma cells via cell cycle block
|
Cancer Biology & Therapy (IF 4.875)
|
2012
|
13(2):77-84
|
Guo H, Hu X,, Qian G, Zhang J
|
Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation
|
Int J Biochem Cell Biol (IF 5.652)
|
2012
|
44(9):1465-72
|
Huang X, Wang L, Zhang H, Wang H, Zhao X, Qian G, Hu J,, Fan X
|
Therapeutic efficacy by targeting correction of notch1-induced aberrants in uveal tumors
|
PLoS ONE (IF 3.752)
|
2012
|
7(8):44301-0
|
Yao Y, Wang L, Zhang H, Wang H, Zhao X, Zhang Y, Zhang L, Fan X, Qian G, Hu J,
|
A Novel Anticancer Therapy That Simultaneously Targets Aberrant p53 and Notch Activities in Tumors
|
PLoS ONE (IF 3.752)
|
2012
|
7(10):46627-0
|
Fan J, Zhou Y, Huang X, Zhang L, Yao Y, Song X, Chen J, Hu J,, Song H, Fan X.
|
The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
|
Hum Reprod (IF 6.353)
|
2012
|
27(11):3347-57
|
Zhang H, Niu B, Hu JF,, Wang H, Li T, Ling J, Steelman BN, Qian G, Hoffman AR.
|
Interruption of intrachromosomal looping by CTCF decoy proteins abrogates genomic imprinting of human insulin-like growth factor II
|
Journal of Cell biology (IF 8.077)
|
2011
|
193(3):475-87
|
Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF,
|
Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1.
|
Cancer (IF 6.921)
|
2011
|
117(1):86-95
|
Xu H, Ni P, Chen C, Yao Y, Zhao X, Qian G, Fan X,
|
SP1 suppresses phorbol 12-myristate 13-acetate induced up-regulation of human regucalcin expression in liver cancer cells.
|
Mol Cell Biochem (IF 3.842)
|
2011
|
355(1):9-15
|
Song X, Zhou Y, Jia R, Xu X, Wang H, Hu J,, Fan X
|
Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.
|
Investigative Ophthalmology and Vision Science(IF 4.925)
|
2010
|
51(5):2626-35
|
Zhang P, Ying L, Xu R,, Mei W, Li F, Dai B, Lu J, Qian G
|
Tumor-Specific, Hypoxia-Regulated WWOX Expression Adenovirus Inhibits Human Non-Small Cell Lung Cancer Growth in Vivo.
|
Human Gene Therapy (IF 4.793)
|
2010
|
21(1):27-39
|
Zhang J, Huang S, Zhang H, Wang H, Guo H, Qian G, Fan X, Lu J, Hoffman AR, Hu JF,
|
Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3’-UTR microRNA.
|
Int J Cancer (IF 7.316)
|
2010
|
126(9):2229-2239
|
Zhang J, Guo H, Qian G,, Ji H, Hu X, Chen W.
|
MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network
|
Mol Cancer(IF 41.444)
|
2010
|
9(1):211-220
|
Zhou Y, Song X, Jia R, Wang H, Dai L, Xu X, Gu P,, Fan X
|
Radiation-inducible human tumor necrosis factor-related apoptosis inducing ligand (TRAIL) gene therapy:a novel treatment for radioresistant uveal melanoma.
|
Pigment Cell & Melanoma Research(IF 4.159)
|
2010
|
23:661-674
|
Zhang H, Wang H, Zhang J, Qian G, Niu B, Fan X, Lu J, Hoffman AR, Hu JF,
|
Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors.
|
Mol Ther(IF 12.910)
|
2009
|
17 (1):57-64
|
Zhang X, Mei W, Zhang L, Yu H, Zhao X, Fan X, Qian G,
|
Co-expression of P1A35-43/β2m fusion protein and co-stimulatory molecule CD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumor model.
|
Oncol Rep. (IF 4.136)
|
2009
|
22(5):1213-1220
|
Fang L, Wang K, Liu X, Zhang L, Zhang X, Qian L, Lu J, Qian G,
|
A Study on the Anti-Tumor Immunity Induced by Gene-Modified Melanoma B16 Cells.
|
Oncol Rep. (IF 4.136)
|
2008
|
19(6):1589-95
|
Zhao X, Wang L, Sun Y, Ye L, Lu J, Yuan Y, Qian G,
|
The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca(2+) stores.
|
Mol Cell Biochem. (IF 3.842)
|
2008
|
312(1-2):33-8
|
Zhao X, Sun Y, Yu H, Ye L, Zhang L, Lu J, Yuan Y, Qian G,
|
Apoptosis induced by BIK was decreased with RNA interference of caspase-12.
|
Biochem Biophys Res Commun. (IF 3.322)
|
2007
|
359(4):896-901.
|
X. Liu, L. Zhang, X. Zhang, H. Yu, X. Zhao, J. Lu, G. Qian ,
|
The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
|
Int J Oncol. (IF 5.884)
|
2007
|
30(6):1389-1396
|
Yu H, Zhao X, Huang S, Lu J, Qian G,
|
Blocking Notch1 Signaling by RNA Interference can Induce Growth Inhibition in Hela Cells.
|
Int J Gynecol Cancer. (IF 4.661)
|
2007
|
17(2):511-6.
|
Jia RB, Zhang P, Zhou YX, Song X, Liu HY, Wang LZ, Luo M, Lu J,, Fan XQ.
|
VEGF-Targeted RNA Interference Suppresses Angiogenesis and Tumor Growth of Retinoblastoma.
|
Ophthalmic Res. (IF 3.031)
|
2007
|
39(2):108-115.
|
|